Evidence map›Paper›PMID 40029387›Full record

ReviewNaunyn-Schmiedeberg's archives of pharmacology2025

MicroRNAs in HIV infection: dual regulators of viral replication and host immunity.

Reda M Mansour, Gharieb S El-Sayyad, Nehal I Rizk, Sherif S Abdel Mageed, Mohamed Salah Basiouny, Salma A El-Sayed, Salma Zaki Fayez, Moustafa Mahmoud Abdelaziz, Khaled Abuelhaded, Haidy Adel Fahmy and 3 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Reda M MansourZoology and Entomology Department, Faculty of Science, Helwan University, Helwan, 11795, Egypt.
Gharieb S El-SayyadMedical Laboratory Technology Department, Faculty of Applied Health Sciences Technology, Badr University in Cairo (BUC), Badr City, 11829, Cairo, Egypt. Gharieb.El-Saied@buc.edu.eg.ORCID 0000-0001-5410-7936
Nehal I RizkDepartment of Biochemistry, Faculty of Pharmacy and Drug Technology, Egyptian Chinese University, Cairo, 11786, Egypt.
Sherif S Abdel MageedPharmacology and Toxicology Department, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, 11829, Cairo, Egypt.
Mohamed Salah BasiounySchool of Biotechnology, Badr University in Cairo (BUC), Badr City, 11829, Cairo, Egypt.
Salma A El-SayedDepartment of Microbiology, Faculty of Science, Cairo University, Giza, Egypt.
Salma Zaki FayezDepartment of Molecular Biology, School of Biotechnology, Badr University in Cairo (BUC), Badr City, 11829, Cairo, Egypt.
Moustafa Mahmoud AbdelazizDepartment of Molecular Biology, School of Biotechnology, Badr University in Cairo (BUC), Badr City, 11829, Cairo, Egypt.
Khaled AbuelhadedSchool of Biotechnology, Badr University in Cairo (BUC), Badr City, 11829, Cairo, Egypt.
Haidy Adel FahmyDepartment of Pharmaceutical Biotechnology, Badr University in Cairo (BUC), Badr City, 11829, Cairo, Egypt.
Osama A MohammedDepartment of Pharmacology, College of Medicine, University of Bisha, 61922, Bisha, Saudi Arabia.
Mustafa Ahmed Abdel-ReheimDepartment of Pharmacology, College of Pharmacy, Shaqra University, 11961, Shaqra, Saudi Arabia. m.ahmed@su.edu.sa.ORCID 0000-0002-7728-0923
Ahmed S DoghishDepartment of Biochemistry, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, 11829, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that play a crucial role in regulating gene expression by binding to target messenger RNAs (mRNAs), leading to their degradation or translational repression. Over the past few years, significant progress has been made in understanding the role of miRNAs in various biological processes, including viral infections such as human immunodeficiency virus (HIV). HIV infection is characterized by a complex interaction between the virus and the host's immune system, where miRNAs have emerged as key regulators. MiRNAs influence HIV infection by modulating both viral replication and the host immune response. Researchers have identified several host miRNAs that suppress or enhance HIV replication by targeting viral genes or host factors essential for the virus life cycle. Conversely, HIV has evolved mechanisms to manipulate the host's miRNA machinery to its advantage. The virus can downregulate or upregulate specific host miRNAs to create a more favorable environment for replication and persistence. Moreover, HIV infection can alter the expression profiles of various miRNAs in infected cells, which can contribute to immune dysregulation and disease progression. Dysregulation of miRNAs is associated with HIV-associated complications, such as neurocognitive disorders and cardiovascular diseases. Understanding the specific roles of miRNAs in HIV pathogenesis could lead to the development of novel therapeutic strategies, such as miRNA-based therapies, to control HIV infection and its associated comorbidities. Understanding the role of miRNAs in HIV infection reveals their significant influence on the complex interactions between the virus and the host, impacting the course of infection and disease progression. Also, continued research in miRNA-mediated mechanisms in HIV holds the potential for uncovering new insights into viral pathogenesis and developing innovative therapeutic approaches.

Indexed as

HIV-1HIV InfectionsMicroRNAsVirus ReplicationAnimalsHost-Pathogen InteractionsHumansMicroRNAsDiagnosisHuman immunodeficiency virusMiRNAsPathogenesisTherapeutic interventions

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.